By Chelsea Naso ( December 17, 2015, 4:29 PM EST) -- AstraZeneca will take a majority stake in Acerta Pharma for up to $4 billion, giving the U.K. pharmaceutical giant access to a blood cell cancer treatment as part of a greater push to build out its oncology portfolio, the company said Thursday....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.